| VIII Conferencia Bienal Barcelona/Pittsburgh |
|
| La demencia hoy | 23-25 Mayo 2012 |
| VIII Barcelona/Pittsburgh Biennial Conference |
|
| Dementia today | 23TH-25TH May 2012 |
Agenda
Charla "La memoria y la atención. Cambios en la edad adulta" - Jornadas de Puertas Abiertas - Fundació ACE. Institut Català de Neurociències Aplicades
Fecha
22-09-2011 al 22-09-2011
Lugar
Centro Cívico Cotxeres de Sants - Barcelona - España
Organizado por
Fundació ACE. Institut Català de Neurociències Aplicades
Charla "Tipos de memoria y por qué se afectan"- "La respuesta social ante la demencia" - Jornadas de Puertas Abiertas - Fundació ACE. Institut Català de Neurociències Aplicades
Fecha
13-09-2011 al 13-09-2011
Lugar
Centro Cívico Can Deu - Barcelona - España
Organizado por
Fundació ACE. Institut Català de Neurociències Aplicades
"Ageing and Neurodegeneration"
Fecha
01-09-2011 al 04-09-2011
Lugar
Bergisch Gladbach - Alemania
Organizado por
DZNE, the German Center for Neurodegenerative Diseases and the Max Planck Institute for Biology of Ageing
Bibliografía
Articulos
Memory Loss in Alzheimer's Disease: Implications for Development of Therapeutics
Carl A. Gold; Andrew E. Budson
Expert Review of NeurotherapeuticsAño: 2009
Categoría: Memoria
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease marked by a constellation of cognitive disturbances, the earliest and most prominent being impaired episodic memory. Episodic memory refers to the memory system that allows an individual to consciously retrieve a previously experienced item or episode of life. Many recent studies have focused on characterizing how AD pathology impacts particular aspects of episodic memory and underlying mental and neural processes. This review summarizes the findings of those studies and discusses the effects of current and promising treatments for AD on episodic memory. The goal of this review is to raise awareness of the strides that cognitive neuroscientists have made in understanding intact and dysfunctional memory. Knowledge of the specific memorial processes that are impaired in AD may be of great value to basic scientists developing novel therapies and to clinical researchers assessing the efficacy of those therapies.
Enlace: Visitar página web







